$2.5T
Total marketcap
$67.64B
Total volume
BTC 50.12%     ETH 16.15%
Dominance

Hologic, Inc. HOLX.VI Stock

73 EUR {{ price }} 0.689655% {{change_pct}}%
COUNTRY
Austria
Exchange
Vienna
Market Cap
17.14B EUR
LOW - HIGH [24H]
73 - 73 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
37.24
Earnings per share
1.96 EUR

Hologic, Inc. Price Chart

Hologic, Inc. HOLX.VI Financial and Trading Overview

Hologic, Inc. stock price 73 EUR
Previous Close 72.94 EUR
Open 72.94 EUR
Bid 73.4 EUR x 0
Ask 74.7 EUR x 0
Day's Range 72.94 - 72.94 EUR
52 Week Range 62.84 - 80.55 EUR
Volume 0 EUR
Avg. Volume 2 EUR
Market Cap 17.95B EUR
Beta (5Y Monthly) 1.012676
PE Ratio (TTM) 26.050001
EPS (TTM) 1.96 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

HOLX.VI Valuation Measures

Enterprise Value 18.15B EUR
Trailing P/E 26.050001
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.4253435
Price/Book (mrq) 3.3865726
Enterprise Value/Revenue 4.475
Enterprise Value/EBITDA 13.704

Trading Information

Hologic, Inc. Stock Price History

Beta (5Y Monthly) 1.012676
52-Week Change 11.87%
S&P500 52-Week Change 20.43%
52 Week High 80.55 EUR
52 Week Low 62.84 EUR
50-Day Moving Average 75.12 EUR
200-Day Moving Average 72.51 EUR

HOLX.VI Share Statistics

Avg. Volume (3 month) 2 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 246.12M
Float 244.09M
Short Ratio N/A
% Held by Insiders 0.73%
% Held by Institutions 100.05%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends September 24, 2022
Most Recent Quarter (mrq) April 1, 2023
Next Fiscal Year End September 24, 2023

Profitability

Profit Margin 18.56%
Operating Margin (ttm) 23.21%
Gross Margin 62.65%
EBITDA Margin 32.65%

Management Effectiveness

Return on Assets (ttm) 6.20%
Return on Equity (ttm) 14.91%

Income Statement

Revenue (ttm) 4.06B EUR
Revenue Per Share (ttm) 16.29 EUR
Quarterly Revenue Growth (yoy) -28.49%
Gross Profit (ttm) 3.31B EUR
EBITDA 1.32B EUR
Net Income Avi to Common (ttm) 753M EUR
Diluted EPS (ttm) 2.8
Quarterly Earnings Growth (yoy) -52.10%

Balance Sheet

Total Cash (mrq) 2.61B EUR
Total Cash Per Share (mrq) 10.6 EUR
Total Debt (mrq) 2.84B EUR
Total Debt/Equity (mrq) 53.66 EUR
Current Ratio (mrq) 4.41
Book Value Per Share (mrq) 21.538

Cash Flow Statement

Operating Cash Flow (ttm) 959M EUR
Levered Free Cash Flow (ttm) 726.48M EUR

Profile of Hologic, Inc.

Country Austria
State MA
City Marlborough
Address 250 Campus Drive
ZIP 01752
Phone 508 263 2900
Website https://www.hologic.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 6944

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Q&A For Hologic, Inc. Stock

What is a current HOLX.VI stock price?

Hologic, Inc. HOLX.VI stock price today per share is 73 EUR.

How to purchase Hologic, Inc. stock?

You can buy HOLX.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Hologic, Inc.?

The stock symbol or ticker of Hologic, Inc. is HOLX.VI.

Which industry does the Hologic, Inc. company belong to?

The Hologic, Inc. industry is Medical Instruments & Supplies.

How many shares does Hologic, Inc. have in circulation?

The max supply of Hologic, Inc. shares is 234.73M.

What is Hologic, Inc. Price to Earnings Ratio (PE Ratio)?

Hologic, Inc. PE Ratio is 37.24489600 now.

What was Hologic, Inc. earnings per share over the trailing 12 months (TTM)?

Hologic, Inc. EPS is 1.96 EUR over the trailing 12 months.

Which sector does the Hologic, Inc. company belong to?

The Hologic, Inc. sector is Healthcare.